The world's first 3D blood vessel bio-printer, which makes it possible to produce personalized functional organs, has been developed by a Chinese biotechnological company called Sichuan Revotek Co. Ltd., based in Chengdu.
The company said, "The significant breakthrough has been achieved through its self-developed stem cell bio-ink technology, 3D bio-printer and cloud computing platform."
Yang Keng, the company chairman said, "The creative breakthrough in the 3D blood vessel bio-printing means we have mastered the stem cell-based 3D bio-printing technology."
The research team has created a novel type of bio-ink - 'Biosynsphere', whose primary goal is the personalized stem cell bio-printing to pave the way for organ regeneration. Kang said, "We have successfully realized the blood vessel regeneration by relying on the 3D bio-printer, the biosynsphere technology and the data model based on cloud computing."